These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31999272)

  • 1. [Spice intoxication and hyperglycemia].
    Elena-González A; Cuadros-Tito P; Esteban-Gutiérrez G
    An Sist Sanit Navar; 2020 Apr; 43(1):87-91. PubMed ID: 31999272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diabetic ketoacidosis in a context of hyperglycemia addiction.
    Rousseau G; Palmiere C; Dupont V; Verschoore M; Savary C; Jousset N; Rougé-Maillart C
    Int J Legal Med; 2018 May; 132(3):787-790. PubMed ID: 29034415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-Threatening Bleeding and Deaths from Synthetic Cannabinoids.
    Zolot J
    Am J Nurs; 2019 Mar; 119(3):15. PubMed ID: 30801303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.
    Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM
    Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.
    Khullar V; Jain A; Sattari M
    J Gen Intern Med; 2014 Aug; 29(8):1200-4. PubMed ID: 24553958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
    Skryabin VY; Vinnikova MA
    J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxicology of synthetic cannabinoids].
    Mouraouakkil Y; Mounir R; El Cadi MA; Lamsaouri J; Bousliman Y; ElJaoudi R
    Ann Biol Clin (Paris); 2024 Jun; 82(2):151-173. PubMed ID: 38721719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine.
    Sheikh IA; Lukšič M; Ferstenberg R; Culpepper-Morgan JA
    Am J Case Rep; 2014 Dec; 15():584-8. PubMed ID: 25548903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes.
    Turner D; Luzio S; Gray BJ; Bain SC; Hanley S; Richards A; Rhydderch DC; Martin R; Campbell MD; Kilduff LP; West DJ; Bracken RM
    Diabet Med; 2016 Apr; 33(4):506-10. PubMed ID: 26220149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study.
    Radhakutty A; Stranks JL; Mangelsdorf BL; Drake SM; Roberts GW; Zimmermann AT; Stranks SN; Thompson CH; Burt MG
    Diabetes Obes Metab; 2017 Apr; 19(4):571-578. PubMed ID: 27995731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus.
    Yoshihara T; Kumashiro N; Kanazawa Y; Mita T; Sakurai Y; Kawai J; Abe M; Motojima K; Hara K; Yamazaki Y; Kanazawa A; Miwa S; Sato F; Kanno R; Shimizu T; Sakai K; Uchino H; Watada H; Tanaka Y; Kawamori R; Hirose T
    Endocr J; 2006 Feb; 53(1):67-72. PubMed ID: 16543674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on the abuse of three NPS (synthetic cannabinoids, kratom, poppers) among youths in Asia.
    Bae K; Kwon NJ; Han E
    Forensic Sci Int; 2018 Nov; 292():45-49. PubMed ID: 30273913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study.
    Hakimian D; Benson AA; Khoury T; Massarwa M; Israel S; Salameh S; Gershinsky Y; Shapira B; Muszkat M
    BMC Gastroenterol; 2021 Jul; 21(1):274. PubMed ID: 34229620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic cannabinoids and potential reproductive consequences.
    Sun X; Dey SK
    Life Sci; 2014 Feb; 97(1):72-7. PubMed ID: 23827241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015).
    Kasper AM; Ridpath AD; Gerona RR; Cox R; Galli R; Kyle PB; Parker C; Arnold JK; Chatham-Stephens K; Morrison MA; Olayinka O; Preacely N; Kieszak SM; Martin C; Schier JG; Wolkin A; Byers P; Dobbs T
    Clin Toxicol (Phila); 2019 Jan; 57(1):10-18. PubMed ID: 29989463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.
    Truong S; Park A; Kamalay S; Hung N; Meyer JG; Nguyen N; Momenzadeh A
    Nutr Clin Pract; 2019 Oct; 34(5):775-782. PubMed ID: 30693980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy.
    Gosmanov AR; Goorha S; Stelts S; Peng L; Umpierrez GE
    Endocr Pract; 2013; 19(2):231-5. PubMed ID: 23337144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources.
    Heller SR; Frier BM; Hersløv ML; Gundgaard J; Gough SC
    Diabet Med; 2016 Apr; 33(4):471-7. PubMed ID: 26179360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic drug intoxication in children: recognition and management in the emergency department.
    Shah R; Baum CR
    Pediatr Emerg Med Pract; 2018 May; 15(5):1-20. PubMed ID: 29697923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fiasp--another insulin aspart formulation for diabetes.
    Med Lett Drugs Ther; 2018 Jan; 60(1537):6-7. PubMed ID: 29294464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.